Total Payments
$761.60
2024 Payments
$196.20
Companies
14
Transactions
35
Medicare Patients
5,557
Medicare Billing
$396,421
Payment Breakdown by Category
Food & Beverage$761.60 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $761.60 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $169.45 | 4 | $0 (2018) |
| Amgen Inc. | $78.97 | 5 | $0 (2024) |
| LEO Pharma Inc. | $76.45 | 3 | $0 (2021) |
| Genentech USA, Inc. | $74.75 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $72.48 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $60.86 | 3 | $0 (2024) |
| Incyte Corporation | $49.99 | 3 | $0 (2024) |
| GENZYME CORPORATION | $36.77 | 2 | $0 (2024) |
| PFIZER INC. | $36.69 | 2 | $0 (2018) |
| UCB, Inc. | $34.78 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $196.20 | 10 | Janssen Biotech, Inc. ($60.86) |
| 2023 | $135.42 | 8 | Amgen Inc. ($43.46) |
| 2022 | $11.35 | 1 | Amgen Inc. ($11.35) |
| 2021 | $76.45 | 3 | LEO Pharma Inc. ($76.45) |
| 2019 | $25.00 | 1 | Genentech USA, Inc. ($25.00) |
| 2018 | $317.18 | 12 | Galderma Laboratories, L.P. ($169.45) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Inflammation | ||||||
| 05/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Immunology | ||||||
| 05/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Immunology | ||||||
| 04/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Dermatology | ||||||
| 03/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Immunology | ||||||
| 03/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.12 | General |
| Category: Dermatology | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Immunology | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Dermatology | ||||||
| 12/05/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology | ||||||
| 11/27/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Dermatology | ||||||
| 10/30/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: Dermatology | ||||||
| 09/20/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Inflammation | ||||||
| 08/23/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Inflammation | ||||||
| 08/10/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: Immunology | ||||||
| 07/12/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Inflammation | ||||||
| 06/26/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Dermatology | ||||||
| 12/13/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Inflammation | ||||||
| 06/18/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: DERMATOLOGY | ||||||
| 05/05/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: DERMATOLOGY | ||||||
| 05/04/2021 | LEO Pharma Inc. | FINACEA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: DERMATOLOGY | ||||||
| 01/17/2019 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: BioOncology | ||||||
| 12/17/2018 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: BioOncology | ||||||
| 12/14/2018 | Pierre Fabre Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.67 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,693 | 8,108 | $1.7M | $263,492 |
| 2022 | 23 | 1,651 | 2,733 | $669,225 | $116,841 |
| 2021 | 8 | 181 | 281 | $43,893 | $13,051 |
| 2020 | 2 | 32 | 54 | $6,585 | $3,038 |
Total Patients
5,557
Total Services
11,176
Medicare Billing
$396,421
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,044 | 1,464 | $385,032 | $88,588 | 23.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 813 | 1,084 | $329,135 | $44,415 | 13.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 362 | 424 | $160,272 | $30,968 | 19.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 652 | 4,186 | $351,624 | $20,986 | 6.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 106 | 146 | $107,209 | $17,528 | 16.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 159 | 173 | $25,523 | $6,720 | 26.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 24 | 25 | $25,050 | $5,584 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 94 | 94 | $30,174 | $5,530 | 18.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 37 | 38 | $26,444 | $4,848 | 18.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 21 | 21 | $21,957 | $4,829 | 22.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 90 | 115 | $23,575 | $4,518 | 19.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 34 | 54 | $22,626 | $4,338 | 19.2% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 36 | 36 | $50,742 | $3,814 | 7.5% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 17 | 17 | $15,642 | $3,448 | 22.0% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $11,961 | $3,213 | 26.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 24 | 27 | $15,398 | $2,392 | 15.5% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 13 | 13 | $8,729 | $2,202 | 25.2% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $21,307 | $2,012 | 9.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 18 | $16,851 | $1,754 | 10.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 20 | $7,440 | $1,629 | 21.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 16 | 16 | $7,600 | $1,305 | 17.2% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 19 | $12,874 | $993.02 | 7.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $4,693 | $833.42 | 17.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 19 | $3,834 | $635.51 | 16.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 21 | $2,109 | $384.93 | 18.3% |
About Dr. Kevin Mcmullen, M.D
Dr. Kevin Mcmullen, M.D is a Dermatology healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2014. The National Provider Identifier (NPI) number assigned to this provider is 1225442247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Mcmullen, M.D has received a total of $761.60 in payments from pharmaceutical and medical device companies, with $196.20 received in 2024. These payments were reported across 35 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($761.60).
As a Medicare-enrolled provider, Mcmullen has provided services to 5,557 Medicare beneficiaries, totaling 11,176 services with total Medicare billing of $396,421. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Missoula, MT
- Active Since 06/18/2014
- Last Updated 10/25/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1225442247
Products in Payments
- SOOLANTRA (Drug) $115.26
- Otezla (Drug) $78.97
- Erivedge (Biological) $74.75
- COSENTYX (Drug) $72.48
- TREMFYA (Drug) $60.86
- ENSTILAR (Drug) $57.06
- EPIDUO FORTE (Drug) $54.19
- OPZELURA (Drug) $49.99
- EUCRISA (Drug) $36.69
- Bimzelx (Biological) $34.78
- Humira (Biological) $24.95
- DUPIXENT (Drug) $22.37
- FINACEA (Drug) $19.39
- TALTZ (Drug) $17.85
- DUPIXENT (Biological) $14.40
- Sotyktu (Drug) $13.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Missoula
Shannon Foster, M.d, M.D
Dermatology — Payments: $11,217
Dermatology $11,217
Troy Davis, Pa-C, PA-C
Dermatology — Payments: $5,646
Dermatology $5,646
Jessica Sempler, M.d, M.D
Dermatology — Payments: $5,358
Dermatology $5,358
Andrew Tegeder, Md, MD
Dermatology — Payments: $3,539
Dermatology $3,539
Erika Hagstrom, Md, MD
Dermatology — Payments: $1,643
Dermatology $1,643
Jacob Inda, Md, MD
Dermatology — Payments: $1,488
Dermatology $1,488